<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02531451</url>
  </required_header>
  <id_info>
    <org_study_id>2014-004872-47</org_study_id>
    <nct_id>NCT02531451</nct_id>
  </id_info>
  <brief_title>The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise in Healthy Adults</brief_title>
  <acronym>NSAID2015</acronym>
  <official_title>The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, healthy human subjects (18-35 yrs) are be randomised to consume 1200 mg
      ibuprofen or 75 mg acetylsalicylic acid daily during a training period of 8 weeks. During
      these weeks, subjects perform 2-3 supervised strength training sessions (knee extensions).
      Before and after training, muscle volume is measured by MRI, and muscle strength is assessed
      by isokinetic and isoinertial ergometers. Muscle biopsies are obtained from m. vastus
      lateralis to study gene and protein expression of markers regulating muscle protein turnover
      and prostaglandin synthesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Quadriceps muscle volume</measure>
    <time_frame>Baseline and after 8 weeks training</time_frame>
    <description>Measured through MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in muscle gene expression</measure>
    <time_frame>Baseline, 4 weeks and after 8 weeks training</time_frame>
    <description>Through quantitative PCR and microarray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle protein expression</measure>
    <time_frame>Baseline, 4 weeks and after 8 weeks training</time_frame>
    <description>Through Western Blots</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quadriceps muscle strength</measure>
    <time_frame>Baseline and after 8 weeks training</time_frame>
    <description>Measured in strength dynamometers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Skeletal Muscle Mass Regulation</condition>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resistance exercise 20 sessions during 8 weeks Daily consumption of 1200 mg ibuprofen (400 mg x 3) during 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetylsalicylic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Resistance exercise 20 sessions during 8 weeks Daily consumption of 75 mg acetylsalicylic acid (75 mg x 1) during 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <arm_group_label>Ibuprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylsalicylic acid</intervention_name>
    <arm_group_label>Acetylsalicylic acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Considered healthy

          -  Moderately trained

          -  18-35 yrs

        Exclusion Criteria:

          -  Cardiovascular disease

          -  Impaired kidney or liver function

          -  Lower limb injury

          -  Pregnancy

          -  Ulcer or gastrointestinal upsets

          -  Previous reactions to use of NSAID
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tommy Lundberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska Institutet</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2015</study_first_submitted>
  <study_first_submitted_qc>August 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2015</study_first_posted>
  <last_update_submitted>June 27, 2016</last_update_submitted>
  <last_update_submitted_qc>June 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Tommy Lundberg</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Muscle mass</keyword>
  <keyword>strength</keyword>
  <keyword>NSAID</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>resistance exercise</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

